Presentation NY Valves 2025 Impact of SGLT2 Inhibitors on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement Presenter: Tamari Lomaia June 26, 2025 REGISTER for free or LOG IN to view this content NY Valves 2025 Up Next Presentation NY Valves 2025 Impact of Sodium Glucose Co-Transporter 2 Inhibitors on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis Presenter: Ogechukwu Samuel Obi June 26, 2025 More slides + Presentation NY Valves 2025 Readmission Reduction in the Structural Heart Population Using Risk Stratification and Targeted Interventions Presenter: Melissa Todice June 26, 2025 Presentation NY Valves 2025 Impact of Cardiac Damage Staging in Patients With Moderate Aortic Stenosis and Reduced Left Ventricular Ejection Fraction: Insights From the TAVR UNLOAD Trial Presenter: Yukari Kobayashi June 26, 2025 We Recommend Disclosures Nothing to disclose
Presentation NY Valves 2025 Impact of Sodium Glucose Co-Transporter 2 Inhibitors on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis Presenter: Ogechukwu Samuel Obi June 26, 2025
Presentation NY Valves 2025 Readmission Reduction in the Structural Heart Population Using Risk Stratification and Targeted Interventions Presenter: Melissa Todice June 26, 2025
Presentation NY Valves 2025 Impact of Cardiac Damage Staging in Patients With Moderate Aortic Stenosis and Reduced Left Ventricular Ejection Fraction: Insights From the TAVR UNLOAD Trial Presenter: Yukari Kobayashi June 26, 2025